Effect of Atrial Electrical Remodeling on the Efficacy of Antiarrhythmic Drugs: Comparison of Amiodarone with IKr‐ and Ito/IKur‐Blockade In Vivo

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cardiovascular Electrophysiology

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1540-8167.2007.00962.xPMID 17916155
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• In Vitro and In Vivo Effects of the Atrial Selective Antiarrhythmic Compound AVE1231

  2007cited by this paper
• Innovative approaches to anti-arrhythmic drug therapy

  2006cited by this paper
• Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.

  2006cited by this paper
• Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs.

  2005cited by this paper
• Drug therapy for atrial fibrillation: where do we go from here?

  2005cited by this paper
• The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation

  2005cited by this paper
• In Vivo and In Vitro Characterization of the Novel Antiarrhythmic Agent SSR149744C: Electrophysiological, Anti-Adrenergic, and Anti-Angiotensin II Effects

  2004cited by this paper
• Reversal of Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation

  2004cited by this paper
• Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

  2004cited by this paper
• Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.

  2004cited by this paper
• “Early” Class III Drugs for the Treatment of Atrial Fibrillation: Efficacy and Atrial Selectivity of AVE0118 in Remodeled Atria of the Goat

  2004cited by this paper
• Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels

  2004cited by this paper
• Effects of Antiarrhythmic Drugs on Fibrillation in the Remodeled Atrium: Insights Into the Mechanism of the Superior Efficacy of Amiodarone

  2003cited by this paper
• Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs.

  2003cited by this paper
• Electrophysiological and antiarrhythmic effects of the novel IKur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the IKr blockers dofetilide, azimilide, d,l-sotalol and ibutilide

  2002cited by this paper
• Electrophysiologic actions of dl-sotalol in patients with persistent atrial fibrillation.

  2002cited by this paper
• Cellular electrophysiology of atrial fibrillation.

  2002cited by this paper
• Differential effects of dofetilide, amiodarone, and class Ic drugs on left and right atrial refractoriness and left atrial vulnerability in pigs

  2001cited by this paper
• Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.

  2000cited by this paper
• Amiodarone to prevent recurrence of atrial fibrillation.

  2000cited by this paper
• Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model.

  1999cited by this paper
• Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.

  1999cited by this paper
• The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs.

  1999cited by this paper
• Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation.

  1999cited by this paper
• Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent.

  1999cited by this paper
• Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.

  1997cited by this paper
• Evidence for two components of delayed rectifier K+ current in human ventricular myocytes.

  1996cited by this paper
• Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

  1995cited by this paper
• SR 33589, a New Amiodarone‐like Antiarrhythmic Agent: Electrophysiological Effects in Anesthetized Dogs

  1995cited by this paper
• Sustained depolarization-induced outward current in human atrial myocytes. Evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents.

  1993cited by this paper

• Research on atrial fibrillation mechanisms and prediction of therapeutic prospects: focus on the autonomic nervous system upstream pathways

  2023cites this paper
• Anti‐arrhythmic investigations in large animal models of atrial fibrillation

  2021cites this paper
• Dynamics of propagation patterns and anti-arrhythmic mechanisms during atrial fibrillation

  2019cites this paper
• Mechanisms and Drug Development in Atrial Fibrillation

  2018cites this paper
• Low‐Level But Not High‐Level Baroreceptor Stimulation Inhibits Atrial Fibrillation in a Pig Model of Sleep Apnea

  2016cites this paper
• Antiarrhythmic effect of vernakalant in electrically remodeled goat atria is caused by slowing of conduction and prolongation of postrepolarization refractoriness.

  2016cites this paper
• Low-level baroreceptor stimulation suppresses atrial fibrillation by inhibiting ganglionated plexus activity.

  2015cites this paper
• Antiarrhythmic therapy in patients with atrial fibrillation

  2015cites this paper
• The effect of tachycardic irregularity on ventricular repolarization dynamics

  2013cites this paper
• Experimental studies on new therapeutic approaches in atrial fibrillation

  2013cites this paper
• Effects of Electrical Stimulation of Carotid Baroreflex and Renal Denervation on Atrial Electrophysiology

  2013cites this paper
• Renal Sympathetic Denervation Provides Ventricular Rate Control But Does Not Prevent Atrial Electrical Remodeling During Atrial Fibrillation

  2013cites this paper
• Atrial-selective Prolongation of Refractory Period With AVE0118 is Due Principally to Inhibition of Sodium Channel Activity

  2012cites this paper
• Renal Sympathetic Denervation Suppresses Postapneic Blood Pressure Rises and Atrial Fibrillation in a Model for Sleep Apnea

  2012cites this paper
• Combined blockade of early and late activated atrial potassium currents suppresses atrial fibrillation in a pig model of obstructive apnea.

  2011cites this paper
• Mechanisms of termination and prevention of atrial fibrillation by drug therapy.

  2011cites this paper
• Novel pharmacological targets for the rhythm control management of atrial fibrillation.

  2011cites this paper
• Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications.

  2011influential citation
• Cardiovascular drugs inducing QT prolongation: facts and evidence.

  2010cites this paper
• Antiarrhythmic therapy in atrial fibrillation.

  2010cites this paper
• Atrial-selectivesodiumchannel blockforthetreatmentofatrial fibrillation

  2009cites this paper
• Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety.

  2009cites this paper
• I(Kur)/Kv1.5 channel blockers for the treatment of atrial fibrillation.

  2009cites this paper
• Drug discoveries towards Kv1.5 potassium channel.

  2009cites this paper
• Atrial-selective sodium channel block for the treatment of atrial fibrillation

  2009cites this paper
• Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation.

  2009cites this paper
• The Emerging Role of Antiarrhythmic Compounds With Atrial Selectivity in the Management of Atrial Fibrillation

  2009cites this paper
• Novel Pharmacological Targets for the Management of Atrial Fibrillation

  2009cites this paper
• IKur/Kv1.5 channel blockers for the treatment of atrial fibrillation

  2009cites this paper
• I Kur /Kv1.5channelblockersforthe treatmentofatrialfibrillation

  2009cites this paper
• How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?

  2008cites this paper
• How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?

  2008cites this paper
• Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome.

  2008cites this paper
• New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

  2008cites this paper
• Związek między amiodaronem, nowymi lekami przeciwarytmicznymi klasy III oraz innymi lekami a nabytym zespołem długiego QT

  2008cites this paper
• Amiodarone and Atrial Fibrillation

  2007cites this paper
• Methods Catheter-based Rdn in a Patient with Af Renal Sympathetic Denervation Provides Ventricular Rate Control but Does Not Prevent Atrial Electrical Remodeling during Atrial Fibrillation

  year unknowncites this paper